Advertisement

Reactions Weekly

, Volume 1753, Issue 1, pp 161–161 | Cite as

Erlotinib/osimertinib

Acquired drug resistance: 2 case reports
Case report
  • 15 Downloads

Reference

  1. Vojnic M, et al. Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers. Journal of Thoracic Oncology 14: 802-815, No. 5, May 2019. Available from: URL: http://doi.org/10.1016/j.jtho.2018.12.038 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations